Julie Massé

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy

Ithar Gataa, Laura Mezquita, Caroline Rossoni et al. · European Journal of Cancer · 2021 · 71 citations · Full text

Favourable Outcome, Tumor Immunology, Cancer Immunosurveillance +11

Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations

Julie Massé, Caroline Truntzer, Romain Boidot et al. · Modern Pathology · 2019 · 61 citations · Full text

Breast Oncology, Molecular Biology, Pathology +5

ZFPIP/Zfp462 is maternally required for proper early Xenopus laevis development

Audrey Laurent, Julie Massé, Francis Omilli et al. · Developmental Biology · 2008 · 19 citations · Full text

Developmental Biology, Developmental Genetics, Genetics +6

Involvement of ZFPIP/Zfp462 in chromatin integrity and survival of P19 pluripotent cells

Julie Massé, Audrey Laurent, Barbara Nicol et al. · Experimental Cell Research · 2010 · 16 citations

Chromatin, Genome Instability, Chromatin Structure +11

ZFPIP/Zfp462 is involved in P19 cell pluripotency and in their neuronal fate

Julie Massé, Claire Piquet‐Pellorce, Justine Viet et al. · Experimental Cell Research · 2011 · 16 citations

Neuroregeneration, Molecular Neuroscience, Developmental Biology +10